Ausejo, Ayesha Kendra E.
HRN: 26-44-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFUROXIME 750MG (VIAL)
03/18/2026
03/25/2026
IV
250MG
Q8h
PCAP C
Checking Initial Appropriateness
03/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2026
03/26/2026
IV
50mg
Q8
PCAP
Checking Initial Appropriateness
03/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2026
03/26/2026
IV
750mg
Q6
PCAP
Checking Initial Appropriateness